BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung cancer
,
Pancreas
,
Neocentromeres
,
Bleomycin
,
rs2476601
,
ZBTB7A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Ca(II
Summary
General Info
Curated Studies
Most Correlated Studies
Cervical carcinoma HeLa cells treated with casiopeina-II-glycine
Explore Curated Studies Results
Literature
Most Relevant Literature
Enhanced excitability of the hippocampal CA2 region and its contribution to seizure activity in a mo…
Febrile Seizure Causes Deficit in Social Novelty, Gliosis, and Proinflammatory Cytokine Response in …
Reduced Cholecystokinin-Expressing Interneuron Input Contributes to Disinhibition of the Hippocampal…
IP3-mediated Ca2+ release regulates atrial Ca2+ transients and pacemaker function by stimulation of …
Unlocking the Potential of the CA2, CA7, and ITM2C Gene Signatures for the Early Detection of Colore…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab
Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca
Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca
Phase I/II Safety and Immunogenicity of Pandemic Live Attenuated Influenza Vaccine (PLAIV) Candidate…
A Randomized Control Trial of Motor-based Intervention for CAS
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ